Tecvayli and Darzalex combination shows unprecedented progression-free survival in relapsed/refractory multiple myeloma, ...
The results build on evidence U.S. regulators found so compelling last year they proactively awarded J&J a new kind of drug ...
Treatment for stage 3 myeloma is typically divided into phases. The goal is to achieve a deep remission, meaning the cancer ...
Rates of multiple myeloma (MM), the second most common blood cancer in the United States, are increasing and are twice as ...
Decluttering Mom on MSN
Mom of two dismissed as postpartum - but it was aggressive multiple myeloma
By the time a Florida mom of two finally heard the words "multiple myeloma," she had already spent months being told her ...
Teclistamab plus daratumumab delivers unprecedented progression-free survival benefits over standard of care in ...
The mother and daughter received identical diagnoses just over a year apart of multiple myeloma, a blood cancer that occurs ...
The MajesTEC-9 trial showed a 40% reduced risk of death and a 71% reduced risk of disease progression or death with ...
A new "double-pronged" CAR T immunotherapy recognizes two distinct features of multiple myeloma to destroy the cancer more ...
News-Medical.Net on MSN
Multiple myeloma rates increasing twice as high in men than in women
Rates of multiple myeloma (MM), the second most common blood cancer in the United States, are increasing and are twice as ...
Study Finds on MSN
Men face double the odds of advanced multiple myeloma at diagnosis
In A Nutshell Men have double the odds of presenting with stage III multiple myeloma compared to women, even after accounting ...
Men are twice as likely as women to have stage III multiple myeloma at diagnosis and appear to have a greater tumor burden than women, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback